- Sorted by date
- Hybrid Sort
- Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: cancer, breast cancer, lung cancer, lung cancer treatment, prostate cancer
Results 31 to 40 of 68 
New drug comb may lengthen ovarian cancer survival
… cancer, according to a team of researchers in Greece, the UK, and the US. The top
contender appears to be a combination of two types of cancer drugs -- platinums … 
- ├ Babies still an option for those with … — Blogging Baby
- ├ Other highlights in the November 15 JNCI — EurekAlert! - Biology
- ├ Systemic Treatment Before Surgery For Kidney Cancer … — Health News from Medical News Today
- └ all 10 related »
Anti-cancer drug shows early promise in pulmonary hypertension
A drug used to treat kidney cancer can prevent the development of pulmonary
hypertension in rodents. There is no curative therapy for this condition …
- ├ Recurrent breast cancer: Drug shows promise — The Cancer Blog
- ├ Pulmonary Hypertension and COPD — Medscape Pulmonary Medicine Headlines
- ├ Drug That Interrupts A Key Stage Of … — Health News from Medical News Today
- └ all 10 related »
Scientists Harness Diptheria Toxin And Interleukin 2 To Help The …
… drug containing parts of the diptheria toxin appears to work well in patients
with advanced melanoma (skin cancer). [click link for full article] …
- ├ Diptheria Toxin And IL2 To Help Immune … — Health News from Medical News Today
- ├ New cancer treatments use body's own immune … — News-Medical News Feed
- ├ T for two: Scientists show how immune … — EurekAlert! - Breaking News
- └ all 10 related »
Celebrex for treatment of precancerous cervical changes
Filed under: Drug, Prevention, Cervical Cancer, Clinical Trials, Research Back
in the summer of 2000, a year before I was diagnosed with breast cancer, I was told I
had an …
- ├ Women Unaware Cervical Cancer Caused by Virus — LiveScience.com
- ├ Survey: Most Women Don't Know Virus Causes … — FOXNews.com
- ├ New Treatment Finds Success, Long Survival In … — Health News from Medical News Today
- └ all 10 related »
Recurrent breast cancer: Drug shows promise
Filed under: Breast Cancer, Drug, Chemotherapy, Clinical Trials, Research,
Cancer Survivors Patients with breast cancer that have disease progression after
being treated with chemotherapy drugs, anthracyclines and taxanes, are left …
- ├ Novel Vaccine Shows Promise Against Early-stage Breast … — ScienceDaily Headlines
- ├ Check out my breasts — The Cancer Blog
- ├ Aeterna prostate cancer drug shows promise — Pharmaceutical Business Review Latest News
- └ all 10 related »
Histamine, a vasoactive agent with vascular disrupting potential, improves tumour …
F Brunstein, J Rens, S T van Tiel, A M M Eggermont & T L M ten Hagen …
- ├ Abbott expects to double vascular business sales — bizjournals.com Health Care:Pharmaceuticals headlines …
- ├ 'Trojan Horse' agent halts bone metastasis in mice — EurekAlert! - Cancer
- ├ Single-Dose Drug-Loaded Dendrimer Cures Mice of Colon … — PhysOrg.com - latest science and technology news
- └ all 10 related »
Resource Utilisation and Time Commitment Associated with Correction of Anaemia …
The amount of time and the costs involved in treating cancer-induced anemia can be
significant and should be weighed when choosing a treatment plan. Clinical Drug
Investigation …
- ├ Alfa Romeo GT en 147 Q2 op video — Autoblog.nl
- ├ Quality care assessment examines surgical quality for … — EurekAlert! - Breaking News
- ├ Fusion Prostate Cancer: An Early Molecular Event … — ScienceDaily Headlines
- └ all 10 related »
North American gets FDA approval for breast cancer treatment
North American Scientific Inc. got approval from the Food and Drug Administration to
market a high-dose radiation design of its breast cancer treatment, the company said
Tuesday …
- ├ North American Gets Cancer Treatment OK — FDA News News from StratCenter.com
- ├ North American Scientific Announces FDA Clearance of … — FDA News News from StratCenter.com
- ├ Cancer treatment of black women delayed — United Press International - Consumer Health
- └ all 10 related »
Genzyme Increasing Research and Development and Amgen Releases Long-Term Enbrel …
… cancer-drug development company is i …
- ├ Amgen Releases Long-Term Enbrel Data — Bio-Technology News from StratCenter.com
- ├ Genzyme increasing research and development presence in … — bizjournals.com Real Estate:Construction headlines
- ├ Enbrel first biologic with up to 9 … — EurekAlert! - Medicine and Health
- └ all 10 related »
NICE rejects use of cancer drug Tarceva
Tarceva, a lung cancer drug manufactured by Roche, may not be approved in the UK
following a negative recommendation by the National Institute for Health and Clinical
Excellence …
- ├ NICE disapproves the use of cancer drug Tarceva — The Earth Times Online Newspaper
- ├ NICE consults on advice on two treatments … — OnMedica Latest News
- ├ NICE refuse to fund life-prolonging cancer drug … — the Mail online | Health
- └ all 10 related »